{
    "2018-09-19": [
        [
            {
                "time": "2018-10-17",
                "original_text": "Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Investor",
                        "Conference Call",
                        "Third-Quarter Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-16",
                "original_text": "5 Dividend Stocks With 50-Plus Years of Annual Dividend Hikes",
                "features": {
                    "keywords": [
                        "Dividend Stocks",
                        "Annual Dividend Hikes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Taking Stock of Quest Diagnostics’ Recent Acquisitions",
                "features": {
                    "keywords": [
                        "Quest Diagnostics",
                        "Acquisitions"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-14",
                "original_text": "How Quest Diagnostics Is Positioned in 2018",
                "features": {
                    "keywords": [
                        "Quest Diagnostics",
                        "Positioned",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-13",
                "original_text": "J&J Files NDA for Erdafitinib in Urothelial Cancer Indication",
                "features": {
                    "keywords": [
                        "J&J",
                        "NDA",
                        "Erdafitinib",
                        "Urothelial Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "Pharma Stocks: Pfizer’s Revenue Trend and 2018 Estimates",
                "features": {
                    "keywords": [
                        "Pharma Stocks",
                        "Pfizer",
                        "Revenue Trend",
                        "2018 Estimates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-11",
                "original_text": "The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Generic Unit",
                        "NDA",
                        "Urinary Tract Cancer Drug",
                        "G1 Therapeutics",
                        "Prices Offering"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Aduro's Cancer Arm & Strong Collaborations Boost Growth",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Cancer Arm",
                        "Strong Collaborations",
                        "Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}